93 related articles for article (PubMed ID: 28991857)
1. Impact of Histological and Endoscopic Remissions on Clinical Recurrence and Recurrence-free Time in Ulcerative Colitis.
Ponte A; Pinho R; Fernandes S; Rodrigues A; Alberto L; Silva JC; Silva J; Rodrigues J; Sousa M; Silva AP; Proença L; Freitas T; Leite S; Carvalho J
Inflamm Bowel Dis; 2017 Dec; 23(12):2238-2244. PubMed ID: 28991857
[TBL] [Abstract][Full Text] [Related]
2. Transperineal ultrasound predicts endoscopic and histological healing in ulcerative colitis.
Sagami S; Kobayashi T; Aihara K; Umeda M; Morikubo H; Matsubayashi M; Kiyohara H; Nakano M; Ohbu M; Hibi T
Aliment Pharmacol Ther; 2020 Jun; 51(12):1373-1383. PubMed ID: 32383166
[TBL] [Abstract][Full Text] [Related]
3. Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis.
Scarallo L; Fioretti L; Paci M; Naldini S; Renzo S; Barp J; Gissi A; Di Paola M; Villanacci V; Lionetti P
Dig Liver Dis; 2024 Jan; 56(1):43-49. PubMed ID: 37455156
[TBL] [Abstract][Full Text] [Related]
4. The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis.
Lenfant M; Verstockt B; Sabino J; Vermeire S; Ferrante M
Aliment Pharmacol Ther; 2024 Jan; 59(1):64-70. PubMed ID: 37843544
[TBL] [Abstract][Full Text] [Related]
5. Histologic features and predicting prognosis in ulcerative colitis patients with mild endoscopic activity.
Shin SY; Kim HS; Kim K; Choi CW; Moon JM; Kim JW; Joo HJ; Seo J; Sung M; Choi CH
Korean J Intern Med; 2024 Jan; 39(1):68-76. PubMed ID: 38086619
[TBL] [Abstract][Full Text] [Related]
6. Risk of Relapse in Patients With Ulcerative Colitis With Persistent Endoscopic Healing: A Durable Treatment Endpoint.
Jangi S; Holmer AK; Dulai PS; Boland BS; Collins AE; Pham L; Sandborn WJ; Singh S
J Crohns Colitis; 2021 Apr; 15(4):567-574. PubMed ID: 32914194
[TBL] [Abstract][Full Text] [Related]
7. Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.
Iacucci M; Jeffery L; Acharjee A; Nardone OM; Zardo D; Smith SCL; Bazarova A; Cannatelli R; Shivaji UN; Williams J; Gkoutos G; Ghosh S
Inflamm Bowel Dis; 2021 Oct; 27(11):1719-1730. PubMed ID: 34019073
[TBL] [Abstract][Full Text] [Related]
8. Predictors and Etiologies of Clinical Relapse Among Patients With Ulcerative Colitis in Deep Remission.
Zeina T; Gandhi S; Mittal A; Levy AN; Weinstock J; Singh S; Jangi S
J Clin Gastroenterol; 2024 Feb; 58(2):195-199. PubMed ID: 36753459
[TBL] [Abstract][Full Text] [Related]
9. Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T; Yamazaki H; Miyatani Y; Sawada T; Shibuya N; Fukuo Y; Kiyohara H; Morikubo H; Tominaga K; Kakimoto K; Imai T; Yaguchi K; Yamamoto S; Ando K; Nishimata N; Yoshihara T; Andoh A; Hibi T; Matsuoka K;
Aliment Pharmacol Ther; 2024 Jul; 60(1):43-51. PubMed ID: 38651779
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic healing is associated with a reduced risk of biologic treatment failure in patients with ulcerative colitis.
Komatsu A; Toyonaga T; Sumiyoshi N; Tanaka M; Shibuya N; Saruta M
Sci Rep; 2024 Jan; 14(1):303. PubMed ID: 38168776
[TBL] [Abstract][Full Text] [Related]
11. Density of Biopsy Sampling Required to Ensure Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis.
McBride RB; Suarez-Farinas M; Ko HM; Chen X; Liu Q; Harpaz N
Inflamm Bowel Dis; 2023 Nov; 29(11):1706-1712. PubMed ID: 37075483
[TBL] [Abstract][Full Text] [Related]
12. Appendiceal Orifice Inflammation Is Associated with Lower Rate of Complete Endoscopic Remission in Patients with Ulcerative Colitis.
Oh CK; Lee HH; Kim JS; Lee BI; Cho YS
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629170
[TBL] [Abstract][Full Text] [Related]
13. Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights.
Asonuma K; Sagami S; Kobayashi T
Aliment Pharmacol Ther; 2024 Apr; 59(8):1005-1006. PubMed ID: 38523122
[No Abstract] [Full Text] [Related]
14. Letter: Modifying the Mayo endoscopic subscore for improved prognostic insights. Authors' reply.
Lenfant M; Verstockt B; Sabino J; Vermeire S; Ferrante M
Aliment Pharmacol Ther; 2024 Apr; 59(8):1007-1008. PubMed ID: 38523123
[No Abstract] [Full Text] [Related]
15. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
[TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.
Lee SH; Kim MJ; Chang K; Song EM; Hwang SW; Park SH; Yang DH; Kim KJ; Byeon JS; Myung SJ; Yang SK; Ye BD
BMC Gastroenterol; 2017 Oct; 17(1):110. PubMed ID: 29061121
[TBL] [Abstract][Full Text] [Related]
17. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome.
Howell KJ; Kraiczy J; Nayak KM; Gasparetto M; Ross A; Lee C; Mak TN; Koo BK; Kumar N; Lawley T; Sinha A; Rosenstiel P; Heuschkel R; Stegle O; Zilbauer M
Gastroenterology; 2018 Feb; 154(3):585-598. PubMed ID: 29031501
[TBL] [Abstract][Full Text] [Related]
18. Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study.
Lopez RN; Evans HM; Appleton L; Bishop J; Chin S; Mouat S; Gearry RB; Day AS
J Pediatr Gastroenterol Nutr; 2018 May; 66(5):e122-e126. PubMed ID: 29077643
[TBL] [Abstract][Full Text] [Related]
19. Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.
Bonovas S; Nikolopoulos GK; Lytras T; Fiorino G; Peyrin-Biroulet L; Danese S
Br J Clin Pharmacol; 2018 Feb; 84(2):239-251. PubMed ID: 29057539
[TBL] [Abstract][Full Text] [Related]
20. Adalimumab and postoperative complications of elective intestinal resections in Crohn's disease: a propensity score case-matched study.
Kotze PG; Magro DO; Martinez CAR; Saab B; Saab MP; Pinheiro LV; Olandoski M; Yamamoto T; Coy CSR
Colorectal Dis; 2017 Oct; ():. PubMed ID: 29053220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
